ストックスクリーナーアプリを入手
5.88
121.05%
3.22
アフターアワーズ：
5.32
-0.56
-9.52%
前日終値:
$2.66
開ける：
$5.9
24時間の取引高:
124.59M
Relative Volume:
53.22
時価総額：
$192.86M
収益：
-
当期純損益:
$-87.23M
株価収益率:
-1.9798
EPS:
-2.97
ネットキャッシュフロー:
$-82.77M
1週間 パフォーマンス:
+186.83%
1か月 パフォーマンス:
+348.85%
6か月 パフォーマンス:
+289.40%
1年 パフォーマンス:
-31.71%
1日の値動き範囲:
$4.90
$6.34
1週間の範囲:
$1.82
$6.34
52週間の値動き範囲:
$0.8801
$9.935
Pepgen Inc Stock (PEPG) Company Profile
PEPG を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PEPG
Pepgen Inc
|
5.88 | 87.25M | 0 | -87.23M | -82.77M | -2.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
381.87 | 96.56B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.58 | 60.08B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.51 | 61.15B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
711.09 | 44.66B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
328.71 | 36.23B | 3.81B | -644.79M | -669.77M | -6.24 |
Pepgen Inc Stock (PEPG) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-09 | 開始されました | Guggenheim | Buy |
| 2024-12-16 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2024-07-31 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-12-21 | 開始されました | H.C. Wainwright | Buy |
Pepgen Inc (PEPG) 最新ニュース
PepGen Inc. (PEPG) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Form 424B5 PepGen Inc. - StreetInsider
PepGen, Inc. (NASDAQ:PEPG) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
PepGen stock price target raised to $12 from $8 at H.C. Wainwright - Investing.com India
PepGen (NASDAQ:PEPG) Given New $12.00 Price Target at Stifel Nicolaus - MarketBeat
S&P 500 Falls 1%; Accenture Posts Upbeat Earnings - Benzinga
Top Biotech Stocks To Watch TodaySeptember 25th - MarketBeat
Biotech Small Caps Catch Fire On Clinical And Tech News - Finimize
PepGen Stock Skyrockets Over 110% on Breakthrough DM1 Trial Results - Tokenist
Surge in PepGen Stock: What Investors Need to Know - timothysykes.com
Why Is PepGen Stock (PEPG) Up 125% Today? - TipRanks
Unusually active option classes on open September 25th - TipRanks
Is PepGen the Next Big Investment? - StocksToTrade
PepGen (PEPG) Stock: Biotech Surges 145% on Record DM1 Treatment Results - parameter.io
PepGen Reports Highest Splicing Correction In Dystrophy Patients, Stock Doubles - Yahoo Finance
Wedbush Forecasts Strong Price Appreciation for PepGen (NASDAQ:PEPG) Stock - MarketBeat
PepGen price target raised to $9 from $7 at Wedbush - TipRanks
Stocks Moving Premarket: PEPG, WOK, ICU, And Other Gainers & Losers - RTTNews
PepGen (NASDAQ:PEPG) Price Target Raised to $12.00 at HC Wainwright - MarketBeat
PepGen price target raised to $12 from $8 at H.C. Wainwright - TipRanks
PepGen stock soars after reporting highest splicing correction in DM1 patients - Investing.com Canada
PepGen announces public offering of common stock and pre-funded warrants - Investing.com Nigeria
Why PepGen Shares Are Trading Higher By 112%; Here Are 20 Stocks Moving Premarket - Benzinga
PepGen shares more than double after muscle disease drug shows promise in trial - TradingView
PepGen Inc. Announces Positive Phase 1 Study Results - TipRanks
PepGen Prices $100 Million Stock Offering; Shares Soar Pre-Bell - MarketScreener
PepGen (PEPG) Launches $100M Stock Offering to Fund Clinical Trials - GuruFocus
IMRX Soars On Pancreatic Cancer Data, PEPG Sets DM1 Splicing Correction Record, CLPT On Watch - RTTNews
PepGen Announces Pricing of $100 Million Public Offering - BioSpace
PepGen prices common stock offering at $3.20 per share to raise $100m - Investing.com
PepGen prices 31 million shares at $3.20 per share - MarketScreener
PepGen reports positive DM1 treatment data with 53.7% splicing correction By Investing.com - Investing.com Australia
PepGen (PEPG) Stock: Soars 119% Following Major Public Offering Proposal - parameter.io
PepGen Reports Highest Mean Splicing Correction in Myotonic Dystrophy Trial; Shares Jump After Hours - MarketScreener
PepGen reports positive DM1 treatment data with 53.7% splicing correction - Investing.com India
PepGen announces common stock offering, no amount given - TipRanks
PepGen says FREEDOM clinical study achieves all key objectives - TipRanks
PepGen Announces Proposed Public Offering - Business Wire
PepGen Announces Highest Mean Splicing Correction Reported in DM1 Patients - Business Wire
PepGen's (PEPG) Buy Rating Reiterated at Guggenheim - MarketBeat
Is PepGen Inc. reversing from oversold territory2025 Risk Factors & Free Safe Entry Trade Signal Reports - newser.com
Is PepGen Inc. still worth holding after the dipTrade Risk Assessment & High Conviction Buy Zone Alerts - newser.com
Is PepGen Inc. stock poised for growth2025 Market Outlook & Real-Time Market Trend Scan - newser.com
Can trapped investors hope for a rebound in PepGen Inc.Portfolio Value Report & AI Enhanced Trading Alerts - newser.com
What data driven models say about PepGen Inc.’s futureQuarterly Investment Review & Low Drawdown Momentum Ideas - newser.com
Using Bollinger Bands to evaluate PepGen Inc.Quarterly Portfolio Review & Risk Managed Investment Strategies - newser.com
Is PepGen Inc. trending in predictive chart modelsEarnings Trend Report & Stepwise Entry and Exit Trade Signals - newser.com
Can PepGen (NASDAQ:PEPG) Afford To Invest In Growth? - Yahoo Finance
Applying sector rotation models to PepGen Inc.Earnings Miss & Smart Money Movement Tracker - newser.com
Pepgen Inc (PEPG) 財務データ
収益
当期純利益
現金流量
EPS
2.43%
大文字化:
|
ボリューム (24 時間):